PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18509013-8	2008	MPO concentrations were consistently higher in samples collected in serum and heparin plasma tubes than in samples in EDTA or citrate tubes.	Citric Acid	126-133	myeloperoxidase	Homo sapiens	0-3	
9249774-9	1997	Citrate abolished the release of MPO almost completely, whereas LF release was partially inhibited.	Citric Acid	0-7	myeloperoxidase	Homo sapiens	33-36	
22107692-2	2011	This is the first study conducted to examine the potentially additive benefit effect of regional citrate anticoagulation (RCA) on polymorphonuclear (PMN) cell degranulation of myeloperoxidase (MPO) and cytokines production in patients with critically acute kidney injury (AKI) undergoing CVVH treatment.	Citric Acid	97-104	myeloperoxidase	Homo sapiens	176-191	
22107692-2	2011	This is the first study conducted to examine the potentially additive benefit effect of regional citrate anticoagulation (RCA) on polymorphonuclear (PMN) cell degranulation of myeloperoxidase (MPO) and cytokines production in patients with critically acute kidney injury (AKI) undergoing CVVH treatment.	Citric Acid	97-104	myeloperoxidase	Homo sapiens	193-196	
22107692-8	2011	Citrate could significantly decrease systemic pre-filter serum MPO levels from baseline at 6 h (median 43.5 vs. 17.3 ng/mL, P<0.01) as well as IL-8 levels (P<0.05) whereas heparin provided only significant TNF-alpha reduction (P<0.05).	Citric Acid	0-7	myeloperoxidase	Homo sapiens	63-66	
8395934-1	1993	When phenylalanine was incubated with myeloperoxidase (MPO) and NADH in citrate buffer (pH 4.5), o-, m-, and p-tyrosines were identified as hydroxylated products.	Citric Acid	72-79	myeloperoxidase	Homo sapiens	38-53